The present invention relates to an anti-CSF-1 R antibody and binding fragments thereof, DNA encoding the same. host cells comprising said DNA and methods of expressing the antibody or binding fragment in a host cell. The present invention also extends to pharmaceutical compositions comprising the antibody or a binding fragment thereof and use of the antibody. binding fragment and compositions comprising the same in treatment.
